Alopexx, Inc.

Alopexx, Inc. publicly filed a registration statement on Form S-1 on Mar 7, 2022 for a proposed initial public offering on NYSE American under the ticker ALPX, and has not yet priced. Its latest amendment was filed on Sep 17, 2026. The filing shows a price range of $10.00–$12.00 per share. Underwriters named in the filing: ThinkEquity.

Alopexx, Inc. is a clinical-stage biotechnology company developing immune therapeutics to prevent and treat bacterial, fungal and parasitic infections whose pathogens express the antigenic target poly-N-acetyl glucosamine (PNAG).

Status

Filed, not priced

Ticker

ALPX

Exchange

NYSE American

Price range

$10.00–$12.00

First filed

Mar 7, 2022

Latest amendment

Sep 17, 2026

Underwriters

ThinkEquity

Sector

Biotech & pharma

Country / state

MA